1. Home
  2. DOUG vs CBUS Comparison

DOUG vs CBUS Comparison

Compare DOUG & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOUG
  • CBUS
  • Stock Information
  • Founded
  • DOUG 1911
  • CBUS 2010
  • Country
  • DOUG United States
  • CBUS United States
  • Employees
  • DOUG N/A
  • CBUS N/A
  • Industry
  • DOUG Building operators
  • CBUS Agricultural Chemicals
  • Sector
  • DOUG Real Estate
  • CBUS Industrials
  • Exchange
  • DOUG Nasdaq
  • CBUS Nasdaq
  • Market Cap
  • DOUG 142.2M
  • CBUS 120.1M
  • IPO Year
  • DOUG N/A
  • CBUS 2017
  • Fundamental
  • Price
  • DOUG $1.58
  • CBUS $2.44
  • Analyst Decision
  • DOUG
  • CBUS Strong Buy
  • Analyst Count
  • DOUG 0
  • CBUS 3
  • Target Price
  • DOUG N/A
  • CBUS $22.83
  • AVG Volume (30 Days)
  • DOUG 1.0M
  • CBUS 229.3K
  • Earning Date
  • DOUG 02-27-2025
  • CBUS 11-07-2024
  • Dividend Yield
  • DOUG N/A
  • CBUS N/A
  • EPS Growth
  • DOUG N/A
  • CBUS N/A
  • EPS
  • DOUG N/A
  • CBUS N/A
  • Revenue
  • DOUG $966,442,000.00
  • CBUS $4,152,999.00
  • Revenue This Year
  • DOUG $5.28
  • CBUS $132.42
  • Revenue Next Year
  • DOUG $16.40
  • CBUS $97.96
  • P/E Ratio
  • DOUG N/A
  • CBUS N/A
  • Revenue Growth
  • DOUG 1.86
  • CBUS 449.34
  • 52 Week Low
  • DOUG $1.00
  • CBUS $2.17
  • 52 Week High
  • DOUG $2.98
  • CBUS $23.18
  • Technical
  • Relative Strength Index (RSI)
  • DOUG 38.30
  • CBUS 36.14
  • Support Level
  • DOUG $1.49
  • CBUS $2.17
  • Resistance Level
  • DOUG $1.84
  • CBUS $3.31
  • Average True Range (ATR)
  • DOUG 0.12
  • CBUS 0.35
  • MACD
  • DOUG 0.00
  • CBUS -0.00
  • Stochastic Oscillator
  • DOUG 25.79
  • CBUS 24.02

About DOUG Douglas Elliman Inc.

Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate. Business is engaged in two operating segments Real Estate Brokerage and Corporate and other. The firm generates income from Commission and other brokerage revenue from existing home sales, Commission and other brokerage income from development marketing, Property management revenue and Title fees.

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Share on Social Networks: